Pactiv Evergreen Inc. Common stock
PTVE
PTVE was delisted on the 31st of March, 2025.
119 hedge funds and large institutions have $383M invested in Pactiv Evergreen Inc. Common stock in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 43 increasing their positions, 29 reducing their positions, and 11 closing their positions.
173% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 11
48% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 29
16% more funds holding
Funds holding: 103 → 119 (+16)
2% less capital invested
Capital invested by funds: $391M → $383M (-$7.84M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ER
EVR Research
Richmond,
Virginia
|
+$6.53M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$4.77M |
| 3 |
AAM
Advisors Asset Management
Monument,
Colorado
|
+$2.67M |
| 4 |
Millennium Management
New York
|
+$2.35M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$29.6M |
| 2 |
TC
Towle & Co
Denver,
Colorado
|
-$10.8M |
| 3 |
CC
Clearline Capital
New York
|
-$1.64M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$1.23M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$703K |
PTVE Hedge Fund Activity: Q2 2022 in Review
119 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Pactiv Evergreen Inc. Common stock (PTVE) for Q2 2022, worth a combined $383M — down 2% from $391M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new PTVE positions and 11 closed out — a net gain of 19 holders — while 43 added to existing stakes and 29 trimmed.
The largest buyer was EVR Research, adding an estimated $6.53M. The largest seller was JP Morgan Chase, cutting an estimated $29.6M.
- 119 institutional investors held Pactiv Evergreen Inc. Common stock (PTVE) as of Q2 2022, up from 103 in Q1 2022.
- Funds reported $383M of Pactiv Evergreen Inc. Common stock stock for Q2 2022, down 2% quarter-over-quarter.
- 30 funds opened new Pactiv Evergreen Inc. Common stock positions in Q2 2022 and 11 closed out, a net change of +19 holders.
- The largest Pactiv Evergreen Inc. Common stock buyer in Q2 2022 was EVR Research, an estimated $6.53M added.
- The largest Pactiv Evergreen Inc. Common stock seller in Q2 2022 was JP Morgan Chase, an estimated $29.6M sold.
Based on aggregated 13F filings for Q2 2022.